Insider Trading › VRTX › Insiders
VERTEX PHARMACEUTICALS INC / MA
VRTX·Nasdaq·
United States·Insider activity
United States·Insider activity$502.31
-1.19 (-0.24%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
VRTX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
VRTXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, VRTX insiders filed 0 purchases ($0) and 14 sales ($11.0M) on the open market, by 6 insiders. Newest filing Jul 7, 2026 (3 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by VRTX insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$11.0MSales · 180 days
3,822Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of VRTX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
3,822 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −1,500 | $524.99 | $787K | 45.3Kdirect | Jul 2, 2026 | Jul 7, 2026 | Form 4 ↗ |
| McKechnie DuncanEVP, Chief Commercial Officer | Sale | −1,541 | $519.00 | $800K | 11.0Kdirect | Jul 2, 2026 | Jul 7, 2026 | Form 4 ↗ |
| Liu JoyEVP and Chief Legal Officer | Sale | −828 | $502.71 | $416K | 19.1Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −596 | $482.50 | $288K | 15.3Kdirect | Jun 26, 2026 | Jun 30, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −1,020 | $462.17 | $471K | 15.9Kdirect | Jun 18, 2026 | Jun 23, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −4,062 | $450.00 | $1.8M | 17.0Kdirect | Jun 15, 2026 | Jun 17, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −1,745 | $450.00 | $785K | 21.0Kdirect | Jun 5, 2026 | Jun 9, 2026 | Form 4 ↗ |
| Liu JoyEVP and Chief Legal Officer | Sale | −828 | $439.91 | $364K | 20.0Kdirect | Jun 1, 2026 | Jun 3, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −1,974 | $450.00 | $888K | 22.8Kdirect | May 29, 2026 | Jun 2, 2026 | Form 4 ↗ |
| Bunnage Mark E.EVP, Chief Scientific Officer | Sale | −33 | $453.45 | $15K | 7,284direct | May 15, 2026 | May 19, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −1,354 | $453.45 | $614K | 24.7Kdirect | May 15, 2026 | May 19, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −6,988 | $450.00 | $3.1M | 26.1Kdirect | May 12, 2026 | May 14, 2026 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −318 | $423.73 | $135K | 4,924direct | May 4, 2026 | May 5, 2026 | Form 4 ↗ |
| Liu JoyEVP and Chief Legal Officer | Sale | −1,104 | $425.02 | $469K | 20.7Kdirect | May 1, 2026 | May 5, 2026 | Form 4 ↗ |
| Liu JoyEVP and Chief Legal Officer | Sale | −978 | $449.17 | $439K | 21.8Kdirect | Apr 1, 2026 | Apr 3, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,329 | $450.95 | $1.1M | 33.1Kdirect | Mar 27, 2026 | Mar 31, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,329 | $481.79 | $1.1M | 35.4Kdirect | Mar 13, 2026 | Mar 17, 2026 | Form 4 ↗ |
| McKechnie DuncanEVP, Chief Commercial Officer | Sale | −2,633 | $498.42 | $1.3M | 12.5Kdirect | Mar 11, 2026 | Mar 13, 2026 | Form 4 ↗ |
| McKechnie DuncanEVP, Chief Commercial Officer | Sale | −2,437 | $475.30 | $1.2M | 15.1Kdirect | Mar 4, 2026 | Mar 6, 2026 | Form 4 ↗ |
| Liu JoyEVP and Chief Legal Officer | Sale | −892 | $495.96 | $442K | 22.8Kdirect | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −1,725 | $496.95 | $857K | 98.3Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −5,995 | $496.16 | $3.0M | 100.0Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −15.6K | $495.38 | $7.7M | 106.0Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −3,498 | $494.33 | $1.7M | 121.6Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −2,520 | $493.29 | $1.2M | 125.1Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −949 | $491.30 | $466K | 127.6Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −2,725 | $490.54 | $1.3M | 128.5Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −460 | $489.32 | $225K | 131.3Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −3,278 | $488.27 | $1.6M | 131.7Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −2,510 | $487.13 | $1.2M | 135.0Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −240 | $482.84 | $116K | 137.5Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −120 | $481.50 | $58K | 137.8Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −400 | $479.75 | $192K | 137.9Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,329 | $480.31 | $1.1M | 37.7Kdirect | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −357 | $483.36 | $173K | 6,624direct | Feb 26, 2026 | Mar 2, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −260 | $486.35 | $126K | 46.8Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −1,846 | $486.35 | $898K | 55.6Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| McKechnie DuncanEVP, Chief Commercial Officer | Sale | −2,410 | $489.00 | $1.2M | 17.6Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| McKechnie DuncanEVP, Chief Commercial Officer | Sale | −2,500 | $486.35 | $1.2M | 20.0Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Bunnage Mark E.EVP, Chief Scientific Officer | Sale | −620 | $486.35 | $302K | 7,284direct | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −945 | $486.35 | $460K | 13.7Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −668 | $486.35 | $325K | 18.4Kdirect | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −223 | $486.35 | $108K | 6,981direct | Feb 25, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −4,237 | $471.43 | $2.0M | 58.9Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −11.7K | $470.54 | $5.5M | 63.2Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −7,241 | $469.61 | $3.4M | 74.9Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −19.7K | $468.57 | $9.2M | 82.1Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −10.3K | $467.75 | $4.8M | 101.8Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −1,848 | $465.80 | $861K | 112.0Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −2,730 | $465.05 | $1.3M | 113.9Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −920 | $463.91 | $427K | 116.6Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −368 | $473.68 | $174K | 48.6Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Bunnage Mark E.EVP, Chief Scientific Officer | Sale | −1,182 | $473.68 | $560K | 8,486direct | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −1,244 | $473.68 | $589K | 15.7Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −817 | $473.68 | $387K | 20.7Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −638 | $473.68 | $302K | 7,750direct | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −609 | $489.46 | $298K | 49.0Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Bunnage Mark E.EVP, Chief Scientific Officer | Sale | −2,437 | $489.46 | $1.2M | 9,668direct | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −2,476 | $489.46 | $1.2M | 17.0Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −2,031 | $489.46 | $994K | 21.5Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −1,557 | $489.46 | $762K | 8,388direct | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −1,500 | $499.99 | $750K | 46.1Kdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −988 | $499.00 | $493K | 16.8Kdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −266 | $500.00 | $133K | 4,299direct | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −466 | $460.43 | $215K | 51.4Kdirect | Feb 11, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Bunnage Mark E.EVP, Chief Scientific Officer | Sale | −2,021 | $460.43 | $931K | 12.9Kdirect | Feb 11, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −1,925 | $460.43 | $886K | 20.8Kdirect | Feb 11, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −1,751 | $460.43 | $806K | 22.0Kdirect | Feb 11, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −1,376 | $460.43 | $634K | 10.1Kdirect | Feb 11, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −4,500 | $474.99 | $2.1M | 42.3Kdirect | Jan 7, 2026 | Jan 9, 2026 | Form 4 ↗ |
| WAGNER CHARLES F JREVP, CO & FO | Sale | −9,532 | $461.00 | $4.4M | 37.7Kdirect | Jan 6, 2026 | Jan 8, 2026 | Form 4 ↗ |
| WAGNER CHARLES F JREVP, CO & FO | Sale | −7,000 | $461.00 | $3.2M | 37.7Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| WAGNER CHARLES F JREVP, CO & FO | Sale | −7,000 | $451.00 | $3.2M | 44.7Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −4,500 | $449.99 | $2.0M | 46.8Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −2,070 | $455.22 | $942K | 24.0Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −10.4K | $453.34 | $4.7M | 26.1Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −15.7K | $452.20 | $7.1M | 36.5Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −5,809 | $451.20 | $2.6M | 52.1Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −5,880 | $449.84 | $2.6M | 57.9Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −2,320 | $448.78 | $1.0M | 63.8Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,152 | $447.05 | $515K | 66.1Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −7,899 | $445.56 | $3.5M | 67.3Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −4,352 | $444.36 | $1.9M | 75.2Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −2,469 | $443.21 | $1.1M | 79.5Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,320 | $441.26 | $582K | 82.0Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −4,469 | $440.40 | $2.0M | 83.3Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −347 | $449.00 | $156K | 15.3Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −2,500 | $434.58 | $1.1M | 16.9Kdirect | Nov 17, 2025 | Nov 19, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −40 | $442.00 | $18K | 24.0Kdirect | Nov 14, 2025 | Nov 17, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −21.3K | $441.35 | $9.4M | 24.1Kdirect | Nov 14, 2025 | Nov 17, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −32.2K | $440.30 | $14.2M | 45.4Kdirect | Nov 14, 2025 | Nov 17, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,160 | $441.05 | $512K | 24.0Kdirect | Nov 13, 2025 | Nov 17, 2025 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −18.5K | $440.22 | $8.2M | 25.2Kdirect | Nov 13, 2025 | Nov 17, 2025 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −694 | $404.21 | $281K | 15.7Kdirect | Oct 2, 2025 | Oct 3, 2025 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −266 | $386.69 | $103K | 4,565direct | Aug 27, 2025 | Aug 29, 2025 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Purchase | +5,710 | $389.95 | $2.2M | 116.0Kdirect | Aug 6, 2025 | Aug 7, 2025 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Purchase | +4,290 | $389.08 | $1.7M | 110.3Kdirect | Aug 6, 2025 | Aug 7, 2025 | Form 4 ↗ |
| SACHS BRUCE IDirector | Purchase | +3,366 | $389.84 | $1.3M | 45.0Kdirect | Aug 6, 2025 | Aug 7, 2025 | Form 4 ↗ |
| SACHS BRUCE IDirector | Purchase | +1,634 | $389.36 | $636K | 41.6Kdirect | Aug 6, 2025 | Aug 7, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −52 | $424.69 | $22K | 23.3Kdirect | May 15, 2025 | May 19, 2025 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −400 | $505.86 | $202K | 4,831direct | May 2, 2025 | May 5, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −3,231 | $510.00 | $1.6M | 23.3Kdirect | Mar 13, 2025 | Mar 17, 2025 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,298 | $500.00 | $1.6M | 51.7Kdirect | Mar 10, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −3,242 | $499.99 | $1.6M | 51.2Kdirect | Mar 10, 2025 | Mar 12, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −3,231 | $500.00 | $1.6M | 26.5Kdirect | Mar 10, 2025 | Mar 12, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −4,058 | $485.49 | $2.0M | 54.5Kdirect | Mar 4, 2025 | Mar 6, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −3,231 | $490.00 | $1.6M | 29.7Kdirect | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −530 | $475.34 | $252K | 58.5Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −2,650 | $475.34 | $1.3M | 19.4Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −1,272 | $480.00 | $611K | 33.0Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −354 | $480.95 | $170K | 64.0Kdirect | Feb 25, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −1,767 | $480.95 | $850K | 24.5Kdirect | Feb 25, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −884 | $480.95 | $425K | 9,086direct | Feb 25, 2025 | Feb 26, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −848 | $480.95 | $408K | 40.2Kdirect | Feb 25, 2025 | Feb 26, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −1,111 | $480.00 | $533K | 45.0Kdirect | Feb 20, 2025 | Feb 24, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −244 | $455.06 | $111K | 67.7Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −1,657 | $455.06 | $754K | 17.6Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −671 | $455.06 | $305K | 10.8Kdirect | Feb 18, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −310 | $459.83 | $143K | 64.0Kdirect | Feb 11, 2025 | Feb 12, 2025 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −3,433 | $459.87 | $1.6M | 16.3Kdirect | Feb 11, 2025 | Feb 12, 2025 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −1,747 | $459.83 | $803K | 23.2Kdirect | Feb 11, 2025 | Feb 12, 2025 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −1,376 | $459.83 | $633K | 9,953direct | Feb 11, 2025 | Feb 12, 2025 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −15 | $478.56 | $7K | 25.8Kdirect | Nov 15, 2024 | Nov 19, 2024 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,000 | $518.27 | $1.6M | 44.1Kdirect | Nov 11, 2024 | Nov 13, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −15.2K | $515.00 | $7.8M | 75.8Kdirect | Nov 8, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −999 | $461.66 | $461K | 16.7Kdirect | Oct 2, 2024 | Oct 3, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −3,784 | $499.00 | $1.9M | 9,994direct | Aug 30, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −646 | $500.00 | $323K | 4,435direct | Aug 30, 2024 | Sep 4, 2024 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −1,292 | $466.29 | $602K | 4,435direct | Aug 8, 2024 | Aug 12, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $476.75 | $1.1M | 23.3Kdirect | Aug 7, 2024 | Aug 8, 2024 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −5,295 | $508.00 | $2.7M | 40.0Kdirect | Aug 1, 2024 | Aug 2, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −15.2K | $505.00 | $7.7M | 91.0Kdirect | Jul 30, 2024 | Aug 1, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $488.46 | $1.1M | 25.5Kdirect | Jul 24, 2024 | Jul 25, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −15.2K | $497.00 | $7.6M | 106.2Kdirect | Jul 22, 2024 | Jul 24, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $487.34 | $1.1M | 27.8Kdirect | Jul 10, 2024 | Jul 12, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $471.72 | $1.1M | 30.1Kdirect | Jun 26, 2024 | Jun 28, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $478.00 | $1.1M | 32.4Kdirect | Jun 12, 2024 | Jun 13, 2024 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −7,288 | $478.00 | $3.5M | 16.0Kdirect | Jun 12, 2024 | Jun 13, 2024 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,250 | $460.00 | $1.5M | 47.1Kdirect | Jun 3, 2024 | Jun 5, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −2,175 | $460.00 | $1.0M | 49.1Kdirect | Jun 3, 2024 | Jun 5, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −2,250 | $445.00 | $1.0M | 51.3Kdirect | May 31, 2024 | Jun 3, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −2,350 | $439.11 | $1.0M | 53.5Kdirect | May 30, 2024 | Jun 3, 2024 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −2,280 | $445.56 | $1.0M | 34.7Kdirect | May 29, 2024 | May 31, 2024 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,250 | $454.79 | $1.5M | 50.4Kdirect | May 28, 2024 | May 30, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −1,565 | $457.00 | $715K | 121.4Kdirect | May 24, 2024 | May 29, 2024 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −7,073 | $448.00 | $3.2M | 40.0Kdirect | May 22, 2024 | May 24, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −15.2K | $447.00 | $6.8M | 121.4Kdirect | May 20, 2024 | May 22, 2024 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −32 | $430.93 | $14K | 55.3Kdirect | May 15, 2024 | May 17, 2024 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −69 | $430.93 | $30K | 49.7Kdirect | May 15, 2024 | May 17, 2024 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Chief Scientific Officer | Sale | −54 | $430.93 | $23K | 25.8Kdirect | May 15, 2024 | May 17, 2024 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −467 | $402.95 | $188K | 4,435direct | May 2, 2024 | May 3, 2024 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −240 | $419.00 | $101K | 7,500direct | Apr 2, 2024 | Apr 3, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −354 | $425.70 | $151K | 55.8Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −3,004 | $425.70 | $1.3M | 55.3Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −883 | $425.70 | $376K | 16.0Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −5,034 | $425.70 | $2.1M | 49.7Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −883 | $425.70 | $376K | 7,965direct | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −4,239 | $425.70 | $1.8M | 25.8Kdirect | Feb 26, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −360 | $421.77 | $152K | 59.5Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −3,191 | $421.77 | $1.3M | 60.8Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −1,201 | $421.77 | $507K | 18.5Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −3,603 | $421.77 | $1.5M | 59.4Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −3,002 | $421.77 | $1.3M | 34.0Kdirect | Feb 21, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −480 | $420.79 | $202K | 59.8Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −4,254 | $420.79 | $1.8M | 64.0Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −801 | $420.79 | $337K | 19.7Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −4,804 | $420.79 | $2.0M | 63.0Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −4,002 | $420.79 | $1.7M | 37.0Kdirect | Feb 20, 2024 | Feb 21, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −4,655 | $419.16 | $2.0M | 17.9Kdirect | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −4,356 | $419.04 | $1.8M | 22.6Kdirect | Feb 14, 2024 | Feb 16, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −737 | $419.13 | $309K | 26.9Kdirect | Feb 13, 2024 | Feb 14, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −647 | $420.39 | $272K | 27.6Kdirect | Feb 12, 2024 | Feb 14, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −2,009 | $419.22 | $842K | 28.3Kdirect | Feb 12, 2024 | Feb 14, 2024 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −314 | $420.24 | $132K | 68.2Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −3,222 | $420.24 | $1.4M | 74.4Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −1,738 | $418.77 | $728K | 18.3Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off. | Sale | −913 | $420.24 | $384K | 23.1Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −4,295 | $420.24 | $1.8M | 75.7Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −1,374 | $420.24 | $577K | 9,676direct | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −3,145 | $420.24 | $1.3M | 47.6Kdirect | Feb 12, 2024 | Feb 13, 2024 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −6,648 | $419.07 | $2.8M | 2,423direct | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,000 | $405.00 | $1.2M | 43.7Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −17.1K | $407.00 | $7.0M | 108.7Kdirect | Dec 15, 2023 | Dec 19, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −100 | $400.19 | $40K | 9,071direct | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −13.3K | $399.41 | $5.3M | 9,171direct | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −5,098 | $397.00 | $2.0M | 108.7Kdirect | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −8,603 | $399.00 | $3.4M | 56.6Kdirect | Dec 13, 2023 | Dec 15, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −3,000 | $349.88 | $1.0M | 46.7Kdirect | Nov 20, 2023 | Nov 21, 2023 | Form 4 ↗ |
| Sachdev AmitEVP Chief Patient & Ext Af Off | Sale | −35 | $369.92 | $13K | 58.8Kdirect | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −19 | $369.92 | $7K | 32.0Kdirect | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,650 | $380.82 | $2.2M | 29.3Kdirect | Nov 14, 2023 | Nov 16, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −5,097 | $377.00 | $1.9M | 113.8Kdirect | Nov 13, 2023 | Nov 15, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −11.3K | $385.00 | $4.3M | 40.0Kdirect | Nov 6, 2023 | Nov 8, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,651 | $355.92 | $2.0M | 35.0Kdirect | Oct 31, 2023 | Nov 2, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,651 | $373.25 | $2.1M | 40.6Kdirect | Oct 17, 2023 | Oct 19, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −243 | $375.00 | $91K | 3,901direct | Oct 17, 2023 | Oct 19, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −13.0K | $374.00 | $4.8M | 22.4Kdirect | Oct 16, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −242 | $360.00 | $87K | 4,144direct | Oct 6, 2023 | Oct 11, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,651 | $345.28 | $2.0M | 46.3Kdirect | Oct 3, 2023 | Oct 5, 2023 | Form 4 ↗ |
| Biller JonathanEVP and Chief Legal Officer | Sale | −610 | $346.76 | $212K | 10.6Kdirect | Oct 2, 2023 | Oct 3, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,651 | $351.00 | $2.0M | 51.9Kdirect | Sep 19, 2023 | Sep 21, 2023 | Form 4 ↗ |
| Bozic CarmenEVP and CMO | Sale | −5,651 | $352.66 | $2.0M | 57.6Kdirect | Sep 5, 2023 | Sep 7, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −2,500 | $355.00 | $888K | 48.6Kdirect | Aug 23, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Kearney Terrence CDirector | Sale | −10.0K | $350.00 | $3.5M | 6,536direct | Aug 10, 2023 | Aug 14, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −5,750 | $345.79 | $2.0M | 51.1Kdirect | Aug 10, 2023 | Aug 14, 2023 | Form 4 ↗ |
| Sachdev AmitEVP, Chief Patient Officer | Sale | −10.0K | $350.00 | $3.5M | 58.8Kdirect | Aug 10, 2023 | Aug 14, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −63 | $345.51 | $22K | 32.0Kdirect | Aug 9, 2023 | Aug 11, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −242 | $345.51 | $84K | 4,386direct | Aug 9, 2023 | Aug 11, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −3,842 | $357.29 | $1.4M | 40.0Kdirect | Jul 17, 2023 | Jul 18, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −5,711 | $356.75 | $2.0M | 43.8Kdirect | Jul 17, 2023 | Jul 18, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −1,697 | $355.54 | $603K | 49.6Kdirect | Jul 17, 2023 | Jul 18, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −7,828 | $355.00 | $2.8M | 118.9Kdirect | Jul 17, 2023 | Jul 18, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −8,603 | $349.00 | $3.0M | 56.6Kdirect | Jun 15, 2023 | Jun 20, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −82 | $329.82 | $27K | 56.6Kdirect | May 30, 2023 | Jun 1, 2023 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −289 | $329.82 | $95K | 6,838direct | May 30, 2023 | Jun 1, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −2,850 | $350.00 | $998K | 32.0Kdirect | May 8, 2023 | May 9, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,125 | $349.00 | $393K | 35.4Kdirect | May 8, 2023 | May 9, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −422 | $350.03 | $148K | 34.9Kdirect | May 5, 2023 | May 9, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −171 | $350.30 | $60K | 36.5Kdirect | May 5, 2023 | May 9, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −708 | $349.38 | $247K | 36.7Kdirect | May 5, 2023 | May 9, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −728 | $351.60 | $256K | 35.3Kdirect | May 3, 2023 | May 4, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −2,053 | $350.44 | $719K | 36.0Kdirect | May 3, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −700 | $351.59 | $246K | 37.4Kdirect | May 3, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,800 | $350.53 | $631K | 38.1Kdirect | May 3, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −2,008 | $349.22 | $701K | 39.9Kdirect | May 3, 2023 | May 4, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −169 | $353.24 | $60K | 38.1Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −42 | $351.65 | $15K | 38.3Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −1,411 | $350.32 | $494K | 38.3Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −300 | $353.18 | $106K | 41.9Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −1,505 | $350.48 | $527K | 42.2Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| LEIDEN JEFFREY MExecutive Chairman · Director | Sale | −4,645 | $349.48 | $1.6M | 43.7Kdirect | May 2, 2023 | May 4, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −63 | $351.20 | $22K | 4,628direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −163 | $349.82 | $57K | 4,691direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −120 | $348.16 | $42K | 4,854direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −172 | $346.69 | $60K | 4,974direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| Bhatia Sangeeta N.Director | Sale | −62 | $345.93 | $21K | 5,146direct | May 2, 2023 | May 3, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −38 | $340.19 | $13K | 126.7Kdirect | Apr 27, 2023 | May 1, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −1,668 | $339.43 | $566K | 126.7Kdirect | Apr 27, 2023 | May 1, 2023 | Form 4 ↗ |
| Kewalramani ReshmaCEO & President · Director | Sale | −1,611 | $338.69 | $546K | 128.4Kdirect | Apr 27, 2023 | May 1, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −2,625 | $327.43 | $860K | 39.7Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −4,068 | $326.45 | $1.3M | 42.3Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −874 | $325.70 | $285K | 46.4Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −8,026 | $327.48 | $2.6M | 41.2Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −10.4K | $326.46 | $3.4M | 49.2Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| SACHS BRUCE IDirector | Sale | −2,917 | $325.65 | $950K | 59.6Kdirect | Apr 12, 2023 | Apr 14, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −31 | $318.68 | $10K | 47.3Kdirect | Apr 4, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −96 | $317.65 | $30K | 47.3Kdirect | Apr 4, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −90 | $316.76 | $29K | 47.4Kdirect | Apr 4, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −94 | $315.66 | $30K | 47.5Kdirect | Apr 4, 2023 | Apr 6, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −211 | $314.22 | $66K | 47.6Kdirect | Apr 4, 2023 | Apr 6, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −1,768 | $305.38 | $540K | 49.6Kdirect | Mar 24, 2023 | Mar 28, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −16 | $301.13 | $5K | 51.4Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −240 | $299.58 | $72K | 51.4Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −360 | $298.09 | $107K | 51.6Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −240 | $296.30 | $71K | 52.0Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −784 | $295.43 | $232K | 52.2Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −360 | $294.52 | $106K | 53.0Kdirect | Mar 17, 2023 | Mar 21, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −264 | $301.07 | $79K | 49.3Kdirect | Mar 16, 2023 | Mar 20, 2023 | Form 4 ↗ |
| Sanna BastianoEVP, Cell & Genetic Therapies | Sale | −2,482 | $300.54 | $746K | 49.5Kdirect | Mar 16, 2023 | Mar 20, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −62 | $296.77 | $18K | 53.4Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −292 | $295.89 | $86K | 53.4Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −715 | $294.52 | $211K | 53.7Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −1,153 | $293.35 | $338K | 54.4Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −420 | $292.41 | $123K | 55.1Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −24 | $288.31 | $7K | 56.0Kdirect | Mar 13, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −102 | $294.94 | $30K | 56.0Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −27 | $293.61 | $8K | 56.1Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −185 | $292.68 | $54K | 56.2Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −541 | $291.47 | $158K | 56.4Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −30 | $289.44 | $9K | 56.9Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −327 | $288.91 | $94K | 56.9Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −515 | $287.83 | $148K | 57.3Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| WAGNER CHARLES F JREVP & Chief Financial Officer | Sale | −361 | $286.64 | $103K | 57.8Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −20 | $289.29 | $6K | 56.8Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −51 | $288.33 | $15K | 56.8Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −283 | $287.20 | $81K | 56.9Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −800 | $288.92 | $231K | 56.6Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −400 | $287.59 | $115K | 57.4Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −3,834 | $287.16 | $1.1M | 57.8Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −42 | $289.63 | $12K | 7,303direct | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −183 | $288.68 | $53K | 7,345direct | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Ambrose KristenSVP & Chief Accounting Officer | Sale | −982 | $287.25 | $282K | 7,528direct | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −302 | $289.60 | $87K | 32.0Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −300 | $288.74 | $87K | 32.3Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −3,636 | $287.23 | $1.0M | 32.6Kdirect | Feb 27, 2023 | Feb 28, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −200 | $296.31 | $59K | 66.3Kdirect | Feb 22, 2023 | Feb 24, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −394 | $295.38 | $116K | 66.5Kdirect | Feb 22, 2023 | Feb 24, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −1,378 | $294.29 | $406K | 66.9Kdirect | Feb 22, 2023 | Feb 24, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −300 | $292.86 | $88K | 68.3Kdirect | Feb 22, 2023 | Feb 24, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −129 | $291.84 | $38K | 68.6Kdirect | Feb 22, 2023 | Feb 24, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −124 | $294.77 | $37K | 60.5Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −207 | $293.83 | $61K | 60.6Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −145 | $292.85 | $42K | 60.8Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Tatsis OuraniaEVP, Chief Reg. & Quality Off. | Sale | −4 | $291.01 | $1K | 60.9Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −736 | $294.58 | $217K | 68.7Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −1,100 | $293.74 | $323K | 69.4Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −545 | $292.77 | $160K | 70.5Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| Arbuckle Stuart AEVP, COO | Sale | −21 | $291.01 | $6K | 71.1Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −900 | $294.73 | $265K | 40.2Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
| ALTSHULER DAVIDEVP, Global Research and CSO | Sale | −1,843 | $294.03 | $542K | 41.1Kdirect | Feb 21, 2023 | Feb 22, 2023 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →